Member Info for ValueVulture

There was a late reported trade of over a million shares at 7.9p for £83,000 two days ago. It came up on LSE after the market closed so many probably missed it. The share price has strengthened since then so it was most likely a buy

At around 12p this is going for a song(we)

So you like US muscle cars huh? No seat belts in those days. And no filter-tipped cigarettes. You could die suddenly in a crash like James Dean, or slowly and painfully from lung cancer. Speaking of cancer...

It's gotta be the SAAB 900. I bought 100 more than that this morning at 49p

https://en.m.wikipedia.org/wiki/Saab_900

I asked Perplexity 'Does Avacta's affimer technology have applications in cancer therapeutics?'

Answers:

https://www.perplexity.ai/search/Does-Avactas-affimer-QEaVIUCMR66Ko_02dzOKHQ

Is anyone going to the evening meeting tomorrow? I expressed my interest in attending but no confirmation has come through. PR needs an upgrade

This cancer has proved a very tough nut to crack.

https://www.independent.co.uk/news/health/pancreatic-cancer-deaths-uk-b2510720.html

Https://www.theguardian.com/commentisfree/2023/dec/31/britain-stuck-in-doom-loop-system-rigged-against-growth-that-needs-to-change

Https://www.theguardian.com/commentisfree/2023/dec/31/britain-stuck-in-doom-loop-system-rigged-against-growth-that-needs-to-change

What any antibody can do, an affimer can do. Wonder what an affimer-based FAS kill switch activator could do. I expect it would blow the bloody doors off!

https://www.sciencealert.com/scientists-find-kill-switch-that-activates-cancer-cell-death-in-the-lab

Rare cancers taken together as a group are as important (diagnosed in similar numbers) as common cancers such as breast, prostate, colon, etc. The usefulness of established chemotherapy drugs is being studied, with improved outcomes observed

https://www.theguardian.com/science/2023/oct/14/patients-with-rare-cancers-given-hope-by-uk-led-drug-match-trial

https://sponsored.bloomberg.com/article/the-next-tech-revolution-?utm_medium=social&utm_id=customcontent-ARM&utm_source=Twitter&utm_campaign=Business-Paid&utm_content=Europe-Ad1&twclid=2-3ijxpsvnic2c6zaz6arz901rv

Dr Greger is saying that the contribution of chemo to 5 year survival is a very small percentage, not that the overall 5 yr survival is 1 or 2%. His background is in public health in NYC

Answer: very weakly https://nutritionfacts.org/2022/07/14/how-effective-is-chemotherapy-for-colon-lung-breast-and-prostate-cancers/#:~:text=Although%20chemotherapy%20treatment%20is%20fairly,patients%2C%20only%20146%20live%20for

Squid News
Avacta could generate affimer candidates with the same functionality as this key antibody in as little time as they took creating new affimers to bind to the SARS-CoV-2 antigen - a matter of weeks as I recall
https://go.squidapp.co/n/eD6Ecrq?i=nbf888gD&r=1&t=n

Serious concerns about the Innova test raised by UK experts following FDA advice to "put them in the trash." The UK regulator gave a 2 month extension to its authorisation of the Innova test for home use AFTER the FDA disqualified it. Anybody know what has happened since then? Was a further 'temporary' authorisation granted to Innova? What a messhttps://blogs.bmj.com/bmj/2021/07/11/why-all-the-secrecy-around-innova-lateral-flow-tests/

Dog? OK just lately the volatile share price has made the company look like an aimless elephant. But huge progress has been made while the shares have been kicked around by traders. After 2 years Avacta is now a VERY different animal. Soon this elephant will be galloping, and fast